南华仪器近三年营收情况 郭晨凯 制图 ◎李子健 记者 李五强 连续两年营收在1亿元退市风险警示"红线"之上挣扎的南华仪器，在2024年"冲营收""并公司""倒房 产"一系列的动作之后，再次"涉险"过线。 围绕"增收"，在历年业务营收均未表现出明显季节性波动的情况下，南华仪器在2024年第四季度营 收"突飞猛进"，比2024年上半年营收还高出55%。与此同时，南华仪器在年末匆忙收购两家公司控股 权，为公司营收"添砖加瓦"。 围绕"增利"，南华仪器将一处房产出售给关联方，交易总金额为5257万元。通过此次关联交易，公司 2024年净利润成功实现由负转正。 种种数据和现象表明，南华仪器"连环计"的目的显而易见——规避"披星戴帽"。 营收"踩线"破亿规避"披星" 4月22日晚，南华仪器披露2024年年报，在2020年至2023年连续4年营收同比下滑的背景下，公司2024年 营收同比增长10.79%，达到1.24亿元。 根据《深圳证券交易所创业板股票上市规则（2024年修订）》规定，上市公司出现最近一个会计年度经 审计的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值，且扣除后的营业收入低于1 亿元的，股票交 ...

Core Viewpoint - Five A-share companies will be subject to delisting risk warnings starting April 29, indicating a potential increase in companies facing performance-related risks as financial reports are disclosed [1][2]. Group 1: Delisting Risk Warnings - Five companies, including Lihang Technology and Gengxing Co., announced their stocks will be suspended for one day on April 28 and will receive delisting risk warnings from April 29 [1][2]. - The upcoming busy period for annual and quarterly report disclosures may lead to more companies reporting underperformance or losses, raising the likelihood of delisting risk warnings [2][4]. Group 2: Regulatory Changes - The "new delisting regulations" introduced stricter standards for mandatory delisting, including raising the revenue threshold for loss-making companies on the main board from 100 million to 300 million [2][3]. - The market capitalization delisting threshold has been increased from below 300 million to below 500 million, and the criteria for significant violations leading to delisting have been lowered [2][3]. Group 3: Impact on Market Dynamics - The introduction of dividend risk warnings aims to improve the dividend behavior of listed companies, which is expected to enhance investor returns and promote a positive investment cycle [4]. - The ongoing emphasis by the China Securities Regulatory Commission on solidifying the delisting mechanism is crucial for the healthy development of the capital market [4].

Core Viewpoint - Qinghai Spring (600381.SH) is facing a delisting risk due to financial indicators triggering delisting clauses, with a warning of "ST" (Special Treatment) to be implemented after the 2024 annual report disclosure [1][2]. Financial Performance - The company expects a net profit loss attributable to shareholders of between 187 million to 225 million yuan for 2024, with a revenue forecast of approximately 256 million to 285 million yuan [2]. - The revenue has been revised down from an initial forecast of 310 million to 339 million yuan to below 300 million yuan, which is critical as it is below the 300 million yuan threshold that could trigger delisting [3][4]. Audit and Regulatory Concerns - The initial financial forecast was questioned by the Shanghai Stock Exchange, leading to an inquiry regarding the authenticity of revenue and the nature of business income [4]. - The auditing firm has raised doubts about the credibility of Qinghai Spring's financial statements, indicating potential for a disclaimer or adverse opinion on the 2024 financial report if sufficient audit evidence cannot be obtained [4][5]. Sales and Revenue Issues - Concerns have been raised regarding the sales of Cordyceps, with reported sales of approximately 152 million yuan, but significant accounts receivable of 56.87 million yuan, suggesting issues with the sales model [5]. - The white liquor segment showed abnormal revenue growth in December, accounting for about 50% of annual sales, which is deemed lacking commercial rationale given the overall market conditions [6][7]. Customer Transactions and Revenue Recognition - The company has been scrutinized for recognizing sales revenue from customers who have not yet sold the products, raising questions about the legitimacy of reported sales figures [7][8]. - Specific customers, such as Chengdu Tinghua Ling, reported significant sales but had not achieved corresponding sales post-delivery, indicating potential revenue recognition issues [9][10]. Conclusion - The discrepancies in reported sales figures and the ongoing audit concerns suggest that the financial health of Qinghai Spring is under significant scrutiny, with the upcoming annual report expected to provide further clarity on these issues [12].

Core Viewpoint - The company *ST Weidi (603023)* has eliminated the conditions that triggered the delisting risk warning and has applied to the Shanghai Stock Exchange for the withdrawal of this warning [1] Group 1 - The company has submitted an application to the Shanghai Stock Exchange to revoke the delisting risk warning [1] - The final outcome of the application will depend on the review by the Shanghai Stock Exchange [1] - The company's stock will continue to trade normally during the review period [1]

Core Viewpoint - *ST Dongfang (600811) has received a termination of listing decision from the Shanghai Stock Exchange, with its stock set to be delisted on April 30, 2025, due to a continuous closing price below 1 yuan for 20 trading days [1][2]. Company Summary - *ST Dongfang, officially known as Dongfang Group Co., Ltd., was established in 1992 and is recognized as the first private enterprise in Heilongjiang Province to publicly issue and list stocks. It is also one of the earliest private enterprises in China to undergo shareholding reform and obtain a listing [3]. - The company operates in four major sectors: modern agriculture and health food, finance, port transportation, and new urbanization development [3]. Industry Context - Recently, several companies in the A-share market have faced delisting due to their stock prices falling below 1 yuan. This includes *ST Xulan, *ST Jiayu, *ST Dongfang, *ST Furun, and *ST Jiyao, all of which have triggered the delisting conditions by having closing prices below 1 yuan for 20 consecutive trading days [3]. - Prior to *ST Dongfang, *ST Jiayu received a termination of listing decision from the Shenzhen Stock Exchange on April 25, 2025, for similar reasons [3]. - Other companies, such as *ST Pengbo, have also seen their stock prices drop below 1 yuan, with the latest price reported at 0.65 yuan per share after 9 consecutive trading days below the threshold [3].

ST春天(600381.SH)公告称，因公司2024年度的利润总额、 净利润或者扣除非经常性损益后的净利润孰 低者为负值且扣除与主营业务无关的业务收入和不具备商业实质的收入后的 营业收入低于3亿元，公司 股票将被实施 退市风险警示。股票简称由"ST春天"变更为"*ST春天"，实施起始日为2025年4月30日。 公司将采取措施争取撤销退市风险警示，包括提升大健康板块业务销售业绩、推出新的酒水快消品板块 产品、积极开拓新的业务板块和加强内部控制制度建设。若公司2025年度相关财务指标仍不达标，公司 股票可能被终止上市。 ...

Group 1 - The core point of the news is that *ST Oriental (600811.SH) has been decided to be delisted by the Shanghai Stock Exchange due to serious financial misconduct, with the delisting date set for April 30, 2025 [1] - The company inflated its revenue by a total of 16.13 billion yuan and its costs by 16.073 billion yuan from 2020 to 2023, which accounted for 13.56% to 50.44% of its revenue during those periods [1] - The company has reported significant losses over the years, with net profits of -1.719 billion yuan, -996 million yuan, and -1.557 billion yuan from 2021 to 2023, totaling over 4.2 billion yuan in losses, and an expected loss of 800 million to 1.2 billion yuan in 2024 [1] Group 2 - On March 16, 2023, *ST Oriental was subjected to a major illegal forced delisting, leading to a continuous drop in stock prices after resumption of trading [2] - The chairman Zhang Hongwei was fined 10 million yuan and banned for life from the securities market, while seven other responsible individuals were fined a total of 29 million yuan [2] - As of September 30, 2022, nearly 130,000 shareholders were affected by the company's financial issues [2] Group 3 - Wu Xiaoqiu, a prominent figure in China's financial research, emphasized the need for *ST Oriental to serve as a cautionary case similar to the Enron scandal in the U.S., advocating for severe penalties against the company [4] - He called for the company to face extreme financial penalties and imprisonment for those responsible, highlighting the importance of accountability in the market [4]

Core Viewpoint - The significant decline in Feikai Convertible Bond and Huaxiang Convertible Bond is primarily due to the announcement of early redemption by both companies, leading to a negative conversion premium in the current market environment [1][4][5]. Group 1: Market Reaction - Feikai Convertible Bond dropped by 10.18%, closing at 113.534 CNY per bond, while Huaxiang Convertible Bond fell by 6.97%, closing at 122.764 CNY per bond [2]. - Both convertible bonds experienced a negative conversion premium, indicating a rapid decrease in their time value due to the early redemption announcements [1][4]. Group 2: Company Announcements - Feikai announced that from March 27 to April 25, its stock price had met the condition for early redemption, with 15 trading days closing above 120% of the conversion price of 15.30 CNY per share [4][5]. - Huaxiang similarly triggered its early redemption clause, with its stock price closing above 130% of the conversion price of 11.65 CNY per share for 15 out of 25 trading days [5]. Group 3: Implications of Early Redemption - The early redemption of convertible bonds reduces their time value, compressing the conversion premium to near zero, which negatively impacts bond prices [6]. - Investors are advised to closely analyze the terms of the bonds and adjust their positions to mitigate potential losses from the early redemption [1][6]. Group 4: Broader Market Concerns - Investors should also be aware of the potential delisting risks associated with convertible bonds, particularly as some underperforming companies may trigger delisting scenarios [7][8]. - The case of Puli Pharmaceutical illustrates the risks, as its stock and convertible bonds faced significant declines due to impending delisting, with the convertible bond dropping by 18.13% [8][10].

多数公司触及"净利润为负且营收不到3亿元"的情形 随着2024年报披露，退市新规威力大显。 据不完全统计，4月28日有6家上市公司被实施退市风险警示，29日还将有14家被披星戴帽，这20家公司 均触及财务类退市风险，多数公司触及"净利润为负且营收不到3亿元"的情形。 根据上市公司公告粗略统计，今年以来被实施退市风险警示的公司中，还有10余家触及"净利润为负且 营收不到3亿元"的情形。另有多家公司因为2024年末净资产为负值，被实施退市风险警示。还有些公司 预计触及上述情形，可能被*ST。 近年来存在一个较为普遍的现象，就是面临财务指标、重大违法等情形被强制退市的公司，最终率先被 投资者用脚投出市场。 南开大学金融发展研究院院长田利辉认为，财务指标趋严是退市新规核心，财务类退市将成为主流， 2025年预计有30～40家企业因此退市；同时，规范类、重大违法类退市同步强化，形成多元退市格局。 他称，退市新规的严格执行，标志着A股从"重融资"向"重投资"转型，通过财务指标、交易规则、违法 惩处的多维约束，推动市场形成"有进有出、优胜劣汰"的良性循环。 多数公司触及财务类退市风险 4月28日，6家上市公司被实施退市风险 ...

A股ST公司的队伍持续扩容。 随着上市公司年报密集出炉，A股"披星戴帽"风险集中暴露，一批个股将在本周被实施ST。 4月28日，宝鹰股份、返利科技等多只个股被同日实施ST。其中，ST步森"披星"，股票简称变更为*ST 步森（002569.SZ）；塞隆药业、高斯贝尔、宝鹰股份则"披星戴帽"，摇身一变成为*ST赛隆 （002898.SZ）、*ST高斯（002848.SZ）和*ST宝鹰（002047.SZ）。 紧接着，4月29日还将有多只个股被ST，涉及星光股份（002076.SZ）、太和水（605081.SH）等。据 Wind统计，仅上述两日就有超过20只个股批量被实施退市风险警示。 这些新晋加入ST股大军的公司，多家连年亏损，*ST宝鹰四年间亏掉了55亿，*ST建艺近三年亏损幅度 逐年扩大。一些公司并非首次站在退市边缘，2017年、2020年两度"披星戴帽"之后，宝塔实业的退市风 险再次悬顶。 "ST公司在今年将面临更大的经营和保壳压力。"南开大学金融发展研究院院长田利辉对第一财经记者 表示，退市新规于今年年初正式施行，更多经营业绩差、流动性差的"僵尸企业"将面临退市风险。另据 记者了解，目前，针对部分业绩"变 ...